Sign up to save your podcasts
Or
Share 4 NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 of The Pharmcast)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
4 NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 of The Pharmcast)
This week on the Pharmcast, we talk with Dr. Joseph Lamendola on four New Drug Application (NDA) mistakes to avoid.
Dr. Lamendola is the former VP of U.S. Regulatory Affairs for Bristol-Myers Squibb and Schering-Plough, and now serves as the SVP and leader of YourEncore's Biopharma practice.
Joe has over 20 drug approvals to his name, so we ask Joe to share his life lessons on how to work with the FDA to receive NDA approval and ultimately get life-changing therapies to patients.
View all episodes
By YourEncore, Inc.This week on the Pharmcast, we talk with Dr. Joseph Lamendola on four New Drug Application (NDA) mistakes to avoid.
Dr. Lamendola is the former VP of U.S. Regulatory Affairs for Bristol-Myers Squibb and Schering-Plough, and now serves as the SVP and leader of YourEncore's Biopharma practice.
Joe has over 20 drug approvals to his name, so we ask Joe to share his life lessons on how to work with the FDA to receive NDA approval and ultimately get life-changing therapies to patients.